Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 8, 2016, Pages 2206-2211

  Ma, Xuanyi ^a,b   Qu, Xin ^b   Zhu, Wei ^b   Li, Yi Shuan ^a   Yuan, Suli ^a   Zhang, Hong ^b   Liu, Justin ^c   Wang, Pengrui ^c   Lai, Cheuk Sun Edwin ^b   Zanella, Fabian ^d   Feng, Gen Sheng ^e   Sheikh, Farah ^d   Chien, Shu ^a   Chen, Shaochen ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3D bioprinting; Biomaterials; In vitro hepatic model; IPSC; Tissue engineering

Indexed keywords

ALBUMIN; CYTOCHROME P450 1A2; CYTOCHROME P450 2B6; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; UVOMORULIN; ALBUMINOID;

ADIPOSE DERIVED STEM CELL; ARTICLE; BIOMIMETICS; BIOPRINTING; CELL DIFFERENTIATION; CELL ENCAPSULATION; CELL INTERACTION; CELL MATURATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDODERM; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; LIVER CELL; MESODERM; MONOLAYER CULTURE; PLURIPOTENT STEM CELL; POLYMERIZATION; PRIORITY JOURNAL; THREE DIMENSIONAL PRINTING; TISSUE ENGINEERING; UMBILICAL VEIN ENDOTHELIAL CELL; ANATOMY AND HISTOLOGY; BIOSYNTHESIS; CELL CULTURE TECHNIQUE; CYTOLOGY; INDUCED PLURIPOTENT STEM CELL; LIVER; METABOLISM; PROCEDURES;

ALBUMINS; BIOMIMETICS; BIOPRINTING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; GENE EXPRESSION; HEPATOCYTES; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LIVER; PRINTING, THREE-DIMENSIONAL; TISSUE ENGINEERING;

EID: 84959218765     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1524510113     Document Type: Article

References (46)

1. Kaplowitz N (2005) Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov 4(6): 489-499.
2. Guguen-Guillouzo C, Corlu A, Guillouzo A (2010) Stem cell-derived hepatocytes and their use in toxicology. Toxicology 270(1):3-9.
3. Yoon No D, Lee K-H, Lee J, Lee S-H (2015) 3D liver models on a microplatform: Welldefined culture, engineering of liver tissue and liver-on-a-chip. Lab Chip 15(19): 3822-3837.
4. Bhatia SN, Underhill GH, Zaret KS, Fox IJ (2014) Cell and tissue engineering for liver disease. Sci Transl Med 6(245):245sr2.
5. Sivaraman A, et al. (2005) A microscale in vitro physiological model of the liver: Predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 6(6): 569-591.
6. Hewitt NJ, et al. (2007) Primary hepatocytes: Current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies. Drug Metab Rev 39(1):159-234.
7. Schwartz RE, Fleming HE, Khetani SR, Bhatia SN (2014) Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv 32(2):504-513.
8. Mallanna SK, Duncan SA (2013) Differentiation of hepatocytes from pluripotent stem cells. Curr Protoc Stem Cell Biol 26:1G.4.1-1G.4.13.
9. Kondo Y, et al. (2014) An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity. Drug Metab Pharmacokinet 29(3):237-243.
10. Takayama K, et al. (2013) 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials 34(7):1781-1789.
11. Takebe T, et al. (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499(7459):481-484.
12. Du C, Narayanan K, Leong MF, Wan ACA (2014) Induced pluripotent stem cell-derived hepatocytes and endothelial cells in multi-component hydrogel fibers for liver tissue engineering. Biomaterials 35(23):6006-6014.
13. Takebe T, et al. (2014) Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc 9(2):396-409.
14. Berger DR, Ware BR, Davidson MD, Allsup SR, Khetani SR (2015) Enhancing the functional maturity of induced pluripotent stem cell-derived human hepatocytes by controlled presentation of cell-cell interactions in vitro. Hepatology 61(4):1370-1381.
15. Kim Y, Rajagopalan P (2010) 3D hepatic cultures simultaneously maintain primary hepatocyte and liver sinusoidal endothelial cell phenotypes. PLoS One 5(11):e15456.
16. Kim K, Ohashi K, Utoh R, Kano K, Okano T (2012) Preserved liver-specific functions of hepatocytes in 3D co-culture with endothelial cell sheets. Biomaterials 33(5): 1406-1413.
17. Khademhosseini A, Langer R, Borenstein J, Vacanti JP (2006) Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci USA 103(8):2480-2487.
18. Faulkner-Jones A, et al. (2015) Bioprinting of human pluripotent stem cells and their directed differentiation into hepatocyte-like cells for the generation of mini-livers in 3D. Biofabrication 7(4):044102.
19. Liu Tsang V, et al. (2007) Fabrication of 3D hepatic tissues by additive photopatterning of cellular hydrogels. FASEB J 21(3):790-801.
20. Neiman JAS, et al. (2015) Photopatterning of hydrogel scaffolds coupled to filter materials using stereolithography for perfused 3D culture of hepatocytes. Biotechnol Bioeng 112(4):777-787.
21. Hribar KC, Soman P, Warner J, Chung P, Chen S (2014) Light-assisted direct-write of 3D functional biomaterials. Lab Chip 14(2):268-275.
22. Hribar KC, et al. (2015) Nonlinear 3D projection printing of concave hydrogel microstructures for long-term multicellular spheroid and embryoid body culture. Lab Chip 15(11):2412-2418.
23. Soman P, Chung PH, Zhang AP, Chen S (2013) Digital microfabrication of user-defined 3D microstructures in cell-laden hydrogels. Biotechnol Bioeng 110(11):3038-3047.
24. Gou M, et al. (2014) Bio-inspired detoxification using 3D-printed hydrogel nanocomposites. Nat Commun 5:3774.
25. Kim K, et al. (2014) 3D optical printing of piezoelectric nanoparticle-polymer composite materials. ACS Nano 8(10):9799-9806.
26. Rouvière O, et al. (2006) MR elastography of the liver: Preliminary results. Radiology 240(2):440-448.
27. You J, et al. (2013) Characterizing the effects of heparin gel stiffness on function of primary hepatocytes. Tissue Eng Part A 19(23-24):2655-2663.
28. Baier Leach J, Bivens KA, Patrick CW, Jr, Schmidt CE (2003) Photocrosslinked hyaluronic acid hydrogels: Natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng 82(5):578-589.
29. Si-Tayeb K, Lemaigre FP, Duncan SA (2010) Organogenesis and development of the liver. Dev Cell 18(2):175-189.
30. DeLaForest A, et al. (2011) HNF4A is essential for specification of hepatic progenitors from human pluripotent stem cells. Development 138(19):4143-4153.
31. Baranski JD, et al. (2013) Geometric control of vascular networks to enhance engineered tissue integration and function. Proc Natl Acad Sci USA 110(19):7586-7591.
32. Tsuji W, Rubin JP, Marra KG (2014) Adipose-derived stem cells: Implications in tissue regeneration. World J Stem Cells 6(3):312-321.
33. Tong JZ, Sarrazin S, Cassio D, Gauthier F, Alvarez F (1994) Application of spheroid culture to human hepatocytes and maintenance of their differentiation. Biol Cell 81(1):77-81.
34. Glicklis R, Merchuk JC, Cohen S (2004) Modeling mass transfer in hepatocyte spheroids via cell viability, spheroid size, and hepatocellular functions. Biotechnol Bioeng 86(6):672-680.
35. Chang TT, Hughes-Fulford M (2009) Monolayer and spheroid culture of human liver hepatocellular carcinoma cell line cells demonstrate distinct global gene expression patterns and functional phenotypes. Tissue Eng Part A 15(3):559-567.
36. Chang TT, Hughes-Fulford M (2014) Molecular mechanisms underlying the enhanced functions of three-dimensional hepatocyte aggregates. Biomaterials 35(7):2162-2171.
37. Luebke-Wheeler JL, Nedredal G, Yee L, Amiot BP, Nyberg SL (2009) E-cadherin protects primary hepatocyte spheroids from cell death by a caspase-independent mechanism. Cell Transplant 18(12):1281-1287.
38. Zhou SF, Liu JP, Chowbay B (2009) Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab Rev 41(2):89-295.
39. Guengerich FP (1999) Cytochrome P-450 3A4: Regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol 39:1-17.
40. Backman JT, Granfors MT, Neuvonen PJ (2006) Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: Studies with tizanidine and caffeine. Eur J Clin Pharmacol 62(6):451-461.
41. Faucette SR, et al. (2004) Regulation of CYP2B6 in primary human hepatocytes by prototypical inducers. Drug Metab Dispos 32(3):348-358.
42. Khetani SR, Bhatia SN (2008) Microscale culture of human liver cells for drug development. Nat Biotechnol 26(1):120-126.
43. Hakkola J, et al. (2001) Cytochrome P450 3A expression in the human fetal liver: Evidence that CYP3A5 is expressed in only a limited number of fetal livers. Biol Neonate 80(3):193-201.
44. Fairbanks BD, Schwartz MP, Bowman CN, Anseth KS (2009) Photoinitiated polymerization of PEG-diacrylate with lithium phenyl-2,4,6-trimethylbenzoylphosphinate: Polymerization rate and cytocompatibility. Biomaterials 30(35):6702-6707.
45. Nichol JW, et al. (2010) Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials 31(21):5536-5544.
46. Corstorphine L, Sefton MV (2011) Effectiveness factor and diffusion limitations in collagen gel modules containing HepG2 cells. J Tissue Eng Regen Med 5(2):119-129.